---
cssClass:
- wide
tags:
  - 🧪
---

# `Title:` [[Genetic Algorithms for De Novo Design]]
--- 

- What led me here: [[Drug Discovery]]

Inlinks
```dataview 
list from [[#this.file.name]] and !outgoing([[# this.file.name]]) 
```

# Genetic Algorithms for Structure-Based De Novo Design of Drug Molecules

## Overview

Genetic algorithms (GAs) are a type of evolutionary algorithm that mimic the process of natural selection to solve optimization problems. In the context of structure-based de novo design of drug molecules, GAs are used to generate and optimize potential drug compounds.

## Process

The process typically involves the following steps:

1. **Target Protein Specification**: The user specifies a target protein. This protein is the one that the potential drug compound is intended to interact with.

2. **Compound Generation**: The GA generates a population of potential drug compounds. These compounds are typically represented as strings of data (analogous to chromosomes) that encode the characteristics of the compound.

3. **Docking**: Each potential drug compound is "docked" to the target protein. This involves computationally simulating the interaction between the protein and the compound to determine how well they bind together.

4. **Fitness Evaluation**: Each compound is assigned a fitness score based on how well it binds to the target protein. The better the binding, the higher the fitness score.

5. **Selection**: Compounds with higher fitness scores are more likely to be selected for reproduction. This mimics the process of natural selection, where individuals with advantageous traits are more likely to reproduce and pass on their genes to the next generation.

6. **Breeding**: Selected compounds are "bred" together to produce new compounds. This involves combining the data strings of two parent compounds to produce one or more offspring compounds. This mimics the process of genetic recombination in biological reproduction.

7. **Mutation**: Random changes are made to the data strings of the offspring compounds. This mimics the process of genetic mutation, which introduces new genetic variation into the population.

8. **Iteration**: Steps 3-7 are repeated for multiple generations until a compound with a desired level of fitness is found.

## Applications

The use of GAs in structure-based de novo design of drug molecules has the potential to significantly speed up the drug discovery process. By automating the generation and optimization of potential drug compounds, GAs can explore a much larger chemical space than would be possible with manual methods. This increases the chances of finding effective drug compounds, and reduces the time and cost of drug discovery.